一个白血病的目标与一千个面孔:线粒体.
Beatrice Maffeo1, Cristina Panuzzo1, Amedeo Moraca1
1Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
International journal of molecular sciences
|September 9, 2023
概括
由于克隆异质性和耐性白血病干细胞 (LSCs),急性髓性白血病 (AML) 的生存率仍然很低. 针对代谢途径,包括Venetoclax,为AML治疗提供了新的组合疗法策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 急性髓性白血病 (AML) 呈现出显著的异质性,导致患者的生存率低下.
- 化疗耐药性和疾病复发是由多种AML克隆和持久性白血病干细胞 (LSC) 驱动的.
- 与AML爆发相比,白血病干细胞具有不同的代谢概况,使其能够存活和疾病复发.
研究的目的:
- 审查AML爆发和LSC之间的代谢差异.
- 为了确定线粒体和新陈代谢中的可药物分子通路,用于白血病治疗.
- 突出结合疗法的潜力,包括代谢抑制剂,以提高AML治疗疗效.
主要方法:
- 关于AML中的代谢途径的文献综述.
- 分析与线粒体和细胞代谢相关的分子标.
- 对AML的现有和新型治疗策略的评估.
主要成果:
- 在AML爆发和LSC中,有明显的代谢脆弱性.
- 线粒体和代谢通路在AML中代表了有前途的治疗点.
- 威尼托克拉克斯在特定的AML亚型中显示出显著的疗效,特别是在不适合强化治疗方案的患者中.
结论:
- 针对代谢途径提供了一个有希望的策略,以克服AML化学抵抗和复发.
- 包括代谢抑制剂的组合疗法可以提高治疗结果.
- 对LSC代谢的进一步研究对于开发更有效的AML疗法至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
14.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mitochondrial Membranes
11.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.5K
Mitochondria
13.7K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.7K


